1
项与 Human Allogeneic Mesenchymal Stem Cells(Cystic Fibrosis Foundation Therapeutics) 相关的临床试验A Phase I, Single Center, Open Label, Single Dose, Dose Escalation Study Assessing the Safety and Tolerability of AllogeneiC MEsenchymAl Stem CEll Infusion in Adults With Cystic Fibrosis-CEASE CF
This study is being done to test if it is safe to give stem cells to adult patients with Cystic Fibrosis (CF). The kind of stem cells we are studying are called allogeneic human mesenchymal stem cells or MSCs. MSCs are cells in the body that can grow into different types of cells and respond to various environmental situations. Allogeneic means the cells come from another person (a donor).
This study is only looking at whether or not it is safe to give the stem cells to adults with CF and how the infusion is tolerated. In the future, other studies may be done to see if stem cells can be a new therapeutic treatment for CF.
Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require approval from the U.S. Food and Drug Administration (FDA) before they can be marketed. The FDA has not approved any stem cell-based products for usual medical care, other than some specific blood forming stem cells for certain indications.
100 项与 Human Allogeneic Mesenchymal Stem Cells(Cystic Fibrosis Foundation Therapeutics) 相关的临床结果
100 项与 Human Allogeneic Mesenchymal Stem Cells(Cystic Fibrosis Foundation Therapeutics) 相关的转化医学
100 项与 Human Allogeneic Mesenchymal Stem Cells(Cystic Fibrosis Foundation Therapeutics) 相关的专利(医药)
100 项与 Human Allogeneic Mesenchymal Stem Cells(Cystic Fibrosis Foundation Therapeutics) 相关的药物交易